FBR Analyst Comments on Skirmish Between Express Scripts (ESRX) and Horizon Pharma (HZNP)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Trump says Canada's Bombardier must build jets in US or lose market access
- Qualcomm to issue warrant to Amazon for up to 25M shares
- Wall St slips as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - Mizuho
November 11, 2015 11:57 AM ESTMizuho Securities analyst Irina Koffler reiterated a Buy rating and $34 price target on Horizon Pharma (NASDAQ: HZNP), saying they expect minimal impact from Linden disruption.
Koffler commented, "We spoke with management and learned that Linden processes ~150-200 prescriptions for Duexis, Vimovo, Pennsaid, and... More
DepoMed (DEPO) Sell-Off on Horizon News a 'Buying Opportunity'- Janney
November 11, 2015 11:48 AM ESTJanney Capital analyst Ken Trbovich reiterated a Buy rating and $35 fair value target on DepoMed Inc (NASDAQ: DEPO) calling today's sell-off on bad Horizon Pharma (NASDAQ: HZNP) a "buying opportunity."
Trbovich commented, "Today's sell off is completely... More
Insys Therapeutics (INSY) Trades Lower in Sympathy with Horizon Pharma (HZNP)
November 11, 2015 9:25 AM ESTInsys Therapeutics (NASDAQ: INSY) shares traded lower in sympathy with Horizon... More
Horizon Pharma (HZNP) Responds to Express Scripts' (ESRX) Lawsuit; Says Linden Care Isn't So-Called 'Captive Pharmacy'
November 11, 2015 6:42 AM ESTHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts (NASDAQ: ESRX) and recent allegations:
Our primary concern is for the patients who, based on the profit driven actions of Express Scripts, may be denied access to medicines that are prescribed by their physicians. We are committed to ensuring that regardless of these actions,... More
